Accelus Secures New Growth Financing To Support Continued Commercial Expansion and Pipeline Innovation
Industry Veteran Bernie Haffey Appointed Chairman of Accelus Board of Directors
Industry Veteran Bernie Haffey Appointed Chairman of Accelus Board of Directors
We’re excited to share that Jim Fox has been promoted to Vice President of U.S. Sales! Jim has been instrumental in driving Accelus’ growth in key eastern markets, and in his new role, he’ll continue expanding our national sales presence.
PALM BEACH GARDENS, Fla., Feb. 11, 2025 – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced that its innovative FlareHawk® Interbody Fusion System has received regulatory approval in Brazil. This significant milestone, granted by the Brazilian Health Regulatory Agency (ANVISA), includes both FlareHawk7™ …
Seasoned Financial Leader with 30 Years of Experience Brought on to Help Drive Strategic Growth and Innovation PALM BEACH GARDENS, Fla., June 3, 2024 – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the appointment of Greg Tibbitts as the company’s Interim Chief …
Accelus Announces Greg Tibbitts as Interim Chief Financial Officer Read More »
New Appointment Strengthens Company’s Leadership in Regulatory Compliance and Quality Management PALM BEACH GARDENS, Fla., May 16, 2024 – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the appointment of Chris McKee as Vice President of Regulatory and Quality. With more than …
Accelus Appoints Chris McKee as Vice President of Regulatory & Quality Read More »
PALM BEACH GARDENS, Fla., April 3, 2024 – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, announced today the addition of two new members to its leadership team: Rob German, Vice President of Research & Development, and Luke Perkins, Senior Director of Product Management. …
Accelus Welcomes New R&D and Product Management Leaders to Drive Innovation Read More »
PALM BEACH GARDENS, Fla., March 5, 2024 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, announced today its participation in the prestigious LSI USA ’24 conference at the Monarch Beach Resort, Waldorf Astoria, in Dana Point, Calif. President & Chief Executive …
Accelus President & CEO Kevin McGann to Present at LSI USA ’24 Conference Read More »
Accelus CEO & Industry Veteran Kevin McGann and High-Performance Management Expert Bernie Haffey to Join as New Directors PALM BEACH GARDENS, Fla., February 12, 2024 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, has announced the appointment of two new members …
Accelus Strengthens Leadership with New Board Appointments Read More »
Continued expansion of LineSider Spinal System portfolio offers surgeons increased visibility and versatility PALM BEACH GARDENS, Fla., January 29, 2024 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the launch of the LineSider® Modular-Cortical System. Designed for greater procedural …
Accelus Introduces LineSider Modular-Cortical System for Posterior Fixation Read More »
Cash infusion to provide company with additional resources for accelerated growth PALM BEACH GARDENS, Fla., JANUARY 18, 2024 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, announced today that it has received a significant financial investment through a $20 million debt …
Accelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital Read More »